<DOC>
	<DOC>NCT00827983</DOC>
	<brief_summary>Prospective, open, randomised, parallel, multicentre, two arm trial comparing a new form of luteal support (S.C.) to an approved comparator (vaginal gel).</brief_summary>
	<brief_title>Subcutaneous Progesterone Versus Vaginal Progesterone Gel for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF)</brief_title>
	<detailed_description />
	<mesh_term>Progesterone</mesh_term>
	<criteria>Age 18 42 (upon starting COH); BMI &lt;30 kg/m2; &lt;3 prior ART cycles (IVF, ICSI and related procedures); Baseline (day 23 of cycling) FSH &lt;15 IU/L and E2 &lt;80 pg/mL; Normal uterine cavity as per recent hysterosalpingogram, sonohysterogram or hysteroscopic exam (i.e. no polyp or protruding submucosal fibroid); At least 3 retrieved oocytes; Patient has given written informed consent. Intramural uterine fibroids that distort the uterine cavity or polyps &gt;1 cm; Stage III or IV endometriosis (endometriomas); Hydrosalpinx; History of past poor response to COH resulting in canceling ART; Use of thawed/donated oocytes; Use of thawed/donated embryos; Patients affected by pathologies associated with any contraindication of being pregnant; Hypersensitivity to study medication; Uncontrolled adrenal or thyroid dysfunction; Undiagnosed vaginal bleeding; History of arterial disease; Patients with hepatic impairment; Neoplasias (current) or history of neoplasia that may be responsive to progesterone; High grade cervical dysplasia; Active thrombophlebitis or thromboembolic disorders, or a history of hormoneassociated thrombophlebitis or thromboembolic disorders; History of recurrent pregnancy loss defined as 3 or more spontaneous miscarriages wherein pregnancy developed to a minimum of a gestational sac on TVUS; Participation in a concurrent clinical trial or another trial within the past 2 months; Use of concomitant medications that might interfere with the study evaluation; Preimplantation genetic diagnosis/screening.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Luteal Phase Support in IVF patients</keyword>
</DOC>